The Valley Desk

NCT00603941 · Interventional trial

A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With Paclitaxel

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Anaplastic Thyroid Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov